Jointly sponsored by the Perelman School of Medicine at the University of Pennsylvania and ViralEd, Inc.

This was a simultaneous Broadcast with HIV Grand Rounds from the Perelman School of Medicine at the University of Pennsylvania

Be sure to read through the program overview prior to registering and attending this program.

The registration window for this program is at the bottom of the page.

Series Overview:

The Perelman School of Medicine at the University of Pennsylvania and ViralEd are proud to announce the Viral Hepatitis Grand Rounds. This program is based on the ground-breaking CME activity HIV Grand Rounds that, in partnership with the Perelman School of Medicine at the University of Pennsylvania, has successfully run for over 2 years. These CME-certified sessions combine traditional academic grand rounds with the innovation and convenience of telemedicine. The Viral Hepatitis Grand Rounds from the Perelman School of Medicine at the University of Pennsylvania is delivered live via the Internet every fourth Wednesday of each month at 12:00 pm Eastern Time and are available for on-demand viewing immediately following the live broadcast.

Presentations cover the most important and current topics in hepatitis and are delivered by the top experts in the field. They are designed to be immediately relevant to practicing hepatitis clinicians and many are case-based. The final 10 minutes of each one-hour educational activity consists of a live question and answer period, with the presenting faculty member available to answer questions asked by attendees using the webinar interface. These monthly grand rounds are intended to provide clinicians with convenient and easily accessible knowledge and clinical skills they need to provide the best medical care for their Hepatitis patients.

Each session may be broadcast via your Internet connection in your conference room or auditorium for large groups to view, or individually to your personal computer at your convenience. Simply register at www.viraled.com/hepatitisgrandrounds for easy access.

Target Audience:

The program has been designed for physicians, fellows, residents, medical students, nurses, nurse practitioners, physician assistants and allied health professionals in the medical specialties of Hepatology, Internal Medicine, Family Practice, Gastroenterology, as well as HIV/AIDS practitioners dealing with co-infection, other Infectious Disease specialists, Public Health professionals and other clinicians interested and involved in the care of patients with Hepatitis.

Commercial Support Acknowledgement:

These activities are supported by educational grants from Gilead Sciences Medical Affairs, Boehringer Ingelheim Pharmaceuticals, Inc. and Janssen Pharmaceuticals, Inc.

Learning Objectives for the Series:

Upon completion of the program, participants should be able to:

• Improve knowledge and ability to use epidemiology and risk factors for increased detection of viral hepatitis.
• Increase the rate of testing of viruses associated with hepatitis.
• Improve knowledge, competence and clinical practice in terms of the current standards and guidelines for the management of patients with viral hepatitis.
• Improve the treatment of viral hepatitis in patients co-infected with HIV or other viral infections.

Course Directors:

K. Rajender Reddy, MD Professor of Medicine Professor of Medicine in Surgery Director, Viral Hepaitits Center Perelman School of Medicine at the University of Pennsylvania Philadelphia, Pennsylvania

Mark Sulkowski, MD Professor of Medicine Medical Director, Viral Hepatitis Center Johns Hopkins University School of Medicine Baltimore, Maryland

Faculty:

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Perelman School of Medicine at the University of Pennsylvania and ViralEd, Inc.. The Perelman School of Medicine at the University of Pennsylvania is accredited by the ACCME to provide continuing medical education for physicians.

The following faculty or planning committee members have disclosed that they have no relevant financial relationships with any commercial interests related to the content of this educational activity:

The following faculty or planning committee members have reported the listed relevant financial relationships with commercial interests related to the content of this educational activity:

Discussion of Investigational and/or Off-label Use of commercial products and devices:

The Perelman School of Medicine at the University of Pennsylvania Requires all faculty to disclose any discussion of an investigational and/or off-label use of a pharmaceutical product or device within their presentation. Participants should note that the use of products outside FDA-approved labeling should be considered experimental and are advised to consult current prescribing information for approved indications.

Faculty members will disclose to participants any discussions of off-label and/or investigational uses of pharmaceutical products within their presentations.

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

register: